SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 1, 1995
OXBORO MEDICAL INTERNATIONAL, INC.
(Exact name of Registrant as Specified in its Charter)
Minnesota
(State or Other Jurisdiction of Incorporation)
0-18785 41-1391803
(Commission File Number) (I.R.S. Employer Identification No.)
13828 Lincoln Street N.E., Ham Lake, Minnesota 55304
(Address of Principal Executive Offices) (Zip Code)
Registrant's Telephone number, Including Area Code (612) 755-9516
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Item 4. Changes in Registrant's Certifying Accountant.
On August 1, 1995, the Registrant's Board of Directors approved the
engagement of Grant Thornton LLP as the Registrant's principal independent
accountant.
Prior to the engagement of Grant Thornton LLP, the Registrant had not
consulted Grant Thornton LLP regarding the application of accounting principles
to a specific completed or contemplated transaction or regarding the type of
audit opinion that might be rendered on the Registrant's financial statements.
As there had been no disagreement with the Registrant's former accountants
required to be disclosed pursuant to Item 304(a)(1)(iv) of Regulation S-B (see
Report on Form 8-K dated June 9, 1995), there was no consultation with Grant
Thornton LLP as to any such matter.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
OXBORO MEDICAL INTERNATIONAL, INC.
By /s/ Harley Haase
Harley Haase
Its President
Dated: August 8, 1995